{
    "id": 27248,
    "fullName": "BRCA2 N136Ifs*16",
    "impact": "frameshift",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "BRCA2 N136Ifs*16 likely results in a truncation of the 3418 aa Brca2 protein at aa 136, followed by 16 nonsense amino acids (UniProt.org). N136Ifs*16 has not been characterized, however, due to the effects of other truncation mutations downstream of N136 (PMID: 10570174, PMID: 18607349), N136Ifs*16 is predicted to lead to a loss of Brca2 protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 3274,
                    "pubMedId": 10570174,
                    "title": "Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/10570174"
                },
                {
                    "id": 6349,
                    "pubMedId": 18607349,
                    "title": "Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18607349"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 675,
        "geneSymbol": "BRCA2",
        "terms": [
            "BRCA2",
            "BRCC2",
            "BROVCA2",
            "FACD",
            "FAD",
            "FAD1",
            "FANCD",
            "FANCD1",
            "GLM3",
            "PNCA2",
            "XRCC11"
        ]
    },
    "variant": "N136Ifs*16",
    "createDate": "11/13/2017",
    "updateDate": "11/20/2019",
    "referenceTranscriptCoordinates": {
        "id": 168839,
        "transcript": "NM_000059",
        "gDna": "chr13:g.32325166delA",
        "cDna": "c.407delA",
        "protein": "p.N136Ifs*16",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12300,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with breast cancer harboring the germline mutation, BRCA2 N136Ifs*16, acquired two BRCA2 reversion mutations, V130_N136delinsD and N136_L139del, as detected in cell-free DNA post treatment with Paraplatin (carboplatin), and subsequently, did not respond to treatment with Talazoparib (BMN-673) (PMID: 28765325).",
            "molecularProfile": {
                "id": 28668,
                "profileName": "BRCA2 V130_N136delinsD BRCA2 N136Ifs*16 BRCA2 N136_L139del"
            },
            "therapy": {
                "id": 682,
                "therapyName": "Talazoparib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 10297,
                    "pubMedId": 28765325,
                    "title": "Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28765325"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28666,
            "profileName": "BRCA2 N136Ifs*16",
            "profileTreatmentApproaches": [
                {
                    "id": 16603,
                    "name": "PARP-1 Inhibitor",
                    "profileName": "BRCA2 N136Ifs*16"
                },
                {
                    "id": 16602,
                    "name": "PARP Inhibitor (Pan)",
                    "profileName": "BRCA2 N136Ifs*16"
                }
            ]
        },
        {
            "id": 28668,
            "profileName": "BRCA2 V130_N136delinsD BRCA2 N136Ifs*16 BRCA2 N136_L139del",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 168839,
            "transcript": "NM_000059",
            "gDna": "chr13:g.32325166delA",
            "cDna": "c.407delA",
            "protein": "p.N136Ifs*16",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}